Sign In
Buy PRVB
$24.98
+0 (+0%)
At Close: Jul 24, 2023
Provention Bio: Tzield Finally Approved, But Neutral On Its Commercial Launch
12:44pm, Monday, 02'nd Jan 2023
After the FDA's approval of Tzield and with better-than-expected pricing, we are upgrading to a Buy rating. PRVB's pricing and approval bode well for the stock and de-risk owning it; however, we are n
Why Shares of Provention Bio Went Up 30.3% in November
04:21pm, Monday, 05'th Dec 2022 The Motley Fool
The company got approval for its lead type 1 diabetes therapy.
Why Shares of Provention Bio Went Up 30.3% in November
11:21am, Monday, 05'th Dec 2022
The company got approval for its lead type 1 diabetes therapy.
Is This Biotech Stock a Buy Following a Landmark Approval?
03:15pm, Sunday, 04'th Dec 2022 The Motley Fool
You may not want to be too quick to pull the trigger.
Is This Biotech Stock a Buy Following a Landmark Approval?
10:15am, Sunday, 04'th Dec 2022
You may not want to be too quick to pull the trigger.
Mirati Plays Catch-Up With Amgen, Gilead's 2nd Try With AIDS Drug, Cytokinetics' Adcom Test And More: Key Nov FDA Decisions For Biotech Investors
11:01am, Friday, 02'nd Dec 2022 Benzinga
Food and Drug Administration decisions and advisory committee verdicts slated for November were mostly positive. New molecular entity approvals so far this year trail 2021’s tally by about 35%.
Th
Why American Eagle Outfitters Shares Climbed Over 18%; Here Are 78 Biggest Movers From Yesterday
10:25am, Wednesday, 23'rd Nov 2022 Benzinga
Gainers
Cosmos Holdings Inc. (NASDAQ: COSM) jumped 86.9% to close at $0.3275 on Tuesday after jumping 21% on Monday. Cosmos Health agreed to sell its Sky Premium Life Luxury food supplement brand on
ConocoPhillips To Plunge Over 11%? Plus This Analyst Slashes PT On LiveOne By 25%
11:51am, Monday, 21'st Nov 2022 Benzinga
Societe Generale boosted the price target on ConocoPhillips (NYSE: COP) from $106 to $114. ConocoPhillips shares fell 2% to close at $128.59 on Friday.
HC Wainwright & Co. cut LiveOne, Inc. (NASD
What 5 Analyst Ratings Have To Say About Provention Bio
06:01pm, Friday, 18'th Nov 2022 Benzinga
Over the past 3 months, 5 analysts have published their opinion on Provention Bio (NASDAQ:PRVB) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a
Delta Apparel, Farfetch, American Software And Some Other Big Stocks Moving Lower On Friday
04:01pm, Friday, 18'th Nov 2022 Benzinga
U.S. stocks traded mixed, with the Dow Jones gaining more than 80 points on Friday. Here are some big stocks recording gains in today’s session.
G1 Therapeutics, Inc. (NASDAQ: GTHX) dipped 24% to $
Provention (PRVB) Gets FDA Nod for Drug That Delays T1D Onset
03:15pm, Friday, 18'th Nov 2022 Zacks Investment Research
Following FDA approval, Provention Bio's (PRVB) Tzield is the first disease-modifying therapy in T1D. Tzield can delay the onset of stage 3 T1D in individuals aged eight years and older.
Why Farfetch Shares Are Trading Lower; Here Are 26 Stocks Moving Premarket
12:43pm, Friday, 18'th Nov 2022 Benzinga
Gainers
PaxMedica, Inc. (NASDAQ: PXMD) shares rose 58.1% to $2.45 in pre-market trading. PaxMedica entered into committed equity investment agreement for up to $20 million with Lincoln Park Capital.
Provention Bio gets FDA approval for treatment that can delay onset of Type 1 diabetes
11:36am, Friday, 18'th Nov 2022
Shares of Provention Bio Inc. PRVB, -1.09% were down 3.9% in trading on Friday morning, the day after the Food and Drug Administration approved the company's treatment that can delay the onset of Type
Gap, Palo Alto Networks And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
11:11am, Friday, 18'th Nov 2022 Benzinga
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.
IVERIC bio, Inc. (NASDAQ: ISEE) shares jumped 20.9% to $20.84 in pre-m
Tesla, Amazon, Provention Bio, Polestar, Palo Alto Networks: Musk's Court Case, Job Cuts, Earnings Pull Investor Eyeballs
01:19am, Friday, 18'th Nov 2022 Benzinga
Major Wall Street indices closed in the red and bond yields rose on Thursday as investors and traders digested comments from a Federal Reserve official in the context of potential interest rate hikes
